发明名称 DOSAGE FORMS COMPRISING APIXABAN AND MATRIX FORMER
摘要 The invention relates to oral dosage forms for modified release of apixaban. The invention also relates to methods of preparing said dosage forms and to an agglomerated mixture of matrix former and filler for preparing an oral dosage form for use in the treatment of venous thromboembolism.
申请公布号 US2015272891(A1) 申请公布日期 2015.10.01
申请号 US201314402702 申请日期 2013.05.16
申请人 RATIOPHARM GMBH 发明人 Meergans Dominique;Leutner Dirk
分类号 A61K9/20;A61K9/00;A61K31/4545 主分类号 A61K9/20
代理机构 代理人
主权项 1. Oral dosage form for modified release containing a) particulate, crystalline apixaban and b) matrix former, wherein preferably the apixaban particle size distribution has a D50-value of 5 to 500 μm, and wherein the matrix former is selected from cellulose ether, cellulose ester, starch, gum, shellac, fatty substances, polyvinylchloride, polyvinyl alcohol polyvinyl acetate or copolymers thereof, polymers based on acrylic acid and/or methacrylic acid and ionic exchange resins.
地址 Ulm DE